Comments on Proposed Rule Regarding Approach to PFAS Reporting Requirements and Supplier Notification for Chemicals of Special Concern Share page: Docket Number: EPA–HQ–TRI–2022–0270 Download Document Issues: OTC Medicines Dietary Supplements OTC Medical Devices Other Issues Packaging Sustainability PFAS Related Posts Comments Comments Regarding Amending OTC Monograph M012: Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Human Use May 7, 2025 Letter Letter Regarding Office of Management & Budget Request for Information: Deregulation May 12, 2025 Press Releases and Statements Veteran Scientist & Regulator Joins CHPA’s Senior Management Team May 12, 2025